Profile and outcome of receptor conversion in breast cancer metastases: a nation‐wide multicenter epidemiological study
Zongbi Yi(Wuhan University), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jin‐Hu Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), You‐Lin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Pei Yu(Shanghai Jiao Tong University), Huawei Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Yan(Zhengzhou University), Li Cai(Wenzhou Medical University), Tao Sun(Wuhan University), Xinlan Liu(Yunnan Agricultural University), Tao Huang(Union Hospital), Yongmei Yin(Nanjing Medical University), Yang Shun-e(Xinjiang Medical University), Xi Chen(Baylor College of Medicine), Hui Li(First Affiliated Hospital of Zhengzhou University), Shusen Wang(Sun Yat-sen University), Su Zhang(University of New Mexico), Xiaojia Wang(China Agricultural University), Runxiang Yang(Kunming Medical University), Jiayu Wang(Chongqing Medical University), Quchang Ouyang(Hunan Cancer Hospital), Jianjun He(Hebei Medical University), Xichun Hu(Fudan University Shanghai Cancer Center), Zhongsheng Tong(Tianjin Medical University Cancer Institute and Hospital), Hong‐Yuan Li(Sichuan Cancer Hospital), Yiqun Han(Mayo Clinic), Wenna Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 18
Related Papers
Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
|Cell|2008|2.6k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
|Nature Communications|2018|525
Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide
|International Journal of Cancer|2006|417